Actelion Pharmaceuticals Ltd

Address

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil


Contact

061 565 65 65
061 565 65 00

Info

Actelion is a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland.

Actelion's first drug, Tracleer, is a therapy for pulmonary arterial hypertonia-approved dual endothelin receptor antagonist in Tablet form. Actelion distributes Tracleer through its own offices in the major international markets, so the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and the USA Switzerland. Actelion, founded in 1997, is a leading global company the exploration of the endothelium. The endothelium separates the vessel wall from the Bloodstream.

Actelion is focused on delivering innovative medicines in areas with high medical needs to be developed, developed and marketed.

Translated by google.com




Data Source: HELP.CH your e-guide ®